Daily as of 3 Nov 16:00 ET
- Price
- below both $5.16 vs 50 $6.78 / 200 $8.06
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 28 Jul 2026 · projected 19 bars out
KYTX | Kyverna TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$5.16
-$0.06 (-1.15%)
Kyverna Therapeutics (KYTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $5.16 vs 50 $5.92 / 200 $7.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 28 Jul 2026 | 💀Death moderate | daily | 19 bars out | Not tested |
| 7 Aug 2025 | 🟨Golden steep | daily | 26 bars out | 6 bar cross test |
About KYTX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall